Published in Vaccine Weekly, November 29th, 2006
Gardasil was approved on June 8 by the U.S. Food and Drug Administration (FDA) for use in girls and women ages 9 to 26 years. Gardasil is the first vaccine available for the prevention of HPV types 16- and 18-related cervical cancer, cervical pre-cancers (CIN 2/3 and AIS), vulvar pre-cancers (VIN 2/3) and vaginal pre-cancers (VaIN 2/3)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly